Get the Weekly Intelligence Brief — top committee picks every Sunday.

CBRE vs MPT

CBRE Group vs Medical Properties Trust, Inc. — AI-powered side-by-side comparison
CBRE
CBRE Group
69
Buy
VS
MPT
Medical Properties Trust, Inc.
45
Watch
MetricCBREMPT
AI Score 69 45
Price $147.42 $4.01
P/E Ratio 33.60× -228.41×
ROE 13.0% -6.0%
Revenue Growth YoY
Gross Margin 17.7% 97.2%
Debt / Equity 1.26× 0.02×
Dividend Yield 0.0% 8.7%
RSI (14) 43.8 19.0
Beta 1.193 1.456
Expected Upside +2.4%

AI Committee View

Current Innellis committee reasoning for CBRE versus MPT.
CBRE leads by 24 points.

CBRE scores 69/100 (Buy) versus MPT at 45/100 (Watch).

CBRE Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
MPT Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — price structure making lower highs and lower lows. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Dividend yield of 8.7% pays you to wait — Value
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • ROE of only -2.7% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 2.11 adds balance-sheet risk to the value case — Value
  • Price structure making lower highs and lower lows — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CBRE Full Analysis MPT Full Analysis